FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis

FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis Print this page Basel, August 20, 2020 — Novartis today announced that the US Food and Drug Administration (FDA) has approved Kesimpta® (ofatumumab, formerly OMB157) as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis (RMS), to include clinically… Read More »

Study shows PE-owned hospitals increased charges, profitability while some care metrics improved

Dive Brief: Private equity investment appears to have an impact on the way hospitals conduct business, resulting in significantly higher charges and huge surges in profitability, according to a new study in JAMA Internal Medicine. Researchers from Harvard Medical School, the Harvard T.H. Chan School of Public Health and Massachusetts General Hospital compared the operations of… Read More »

Can b12 help with weight loss

Vitamin B12 is also essential in the metabolism of fatty acids and proteins. This form of anemia, as well as other health issues associated with B deficiency, can be easily treated with injections of the vitamin. If you suspect you have a B12 deficiency, you should get it confirmed through testing and begin researching ways… Read More »